Does DENOSUMAB Cause Prostatic specific antigen increased? 220 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 220 reports of Prostatic specific antigen increased have been filed in association with DENOSUMAB (Bilprevda). This represents 0.2% of all adverse event reports for DENOSUMAB.
220
Reports of Prostatic specific antigen increased with DENOSUMAB
0.2%
of all DENOSUMAB reports
17
Deaths
36
Hospitalizations
How Dangerous Is Prostatic specific antigen increased From DENOSUMAB?
Of the 220 reports, 17 (7.7%) resulted in death, 36 (16.4%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Prostatic specific antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 220 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Prostatic specific antigen increased?
ENZALUTAMIDE (3,731)
LEUPROLIDE (2,432)
ABIRATERONE (1,581)
RADIUM RA-223 DICHLORIDE (449)
RELUGOLIX (335)
BICALUTAMIDE (322)
DOCETAXEL (282)
APALUTAMIDE (251)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)
OLAPARIB (176)
Which DENOSUMAB Alternatives Have Lower Prostatic specific antigen increased Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE